Foracort Inhaler
Formulated to alleviate bronchial constrictions to support steady respiration and target mucosal tissue swelling.
- Category
- Respiratory Health
- Active ingredients
- Formoterol · Budesonide
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 100mcg + 6mcg · 200mcg + 6mcg · 400mcg + 6mcg
Prescription and consultation requirements for Foracort Inhaler vary by destination and are determined by the fulfilment partner.
Foracort Inhaler details
- Conditions
- Asthma · Chronic Obstructive Pulmonary Disease
- Alternative names
- formoterol, budesonide
- Therapeutic class
- Corticosteroid, Long-Acting Beta2-Adrenergic Agonist (LABA) Combination
- Pharmacological class
- Inhaled Bronchodilator and Corticosteroid
- Contraindications
- status asthmaticus; severe hypersensitivity to milk proteins
- Minor side effects
- hoarseness; throat irritation; headache
- Moderate side effects
- oral candidiasis; tachycardia; tremor
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 15–30 minutes
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Ritonavir; Beta Blockers
- Age restrictions
- Approved for patients six years and older.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; adrenal insufficiency, requires immediate medical attention
Patient summary
formulated to alleviate bronchial constrictions to support steady respiration and target mucosal tissue swelling.
Mechanism of action
Budesonide resolves chronic airway swelling while formoterol provides long-acting smooth muscle relaxation.
Pregnancy and breastfeeding
TGA Category C: Benefit must exceed potential fetal risk. Breastfeeding: Consult a clinician.